Buy Side Asset Diligence & Portfolio Strategy

BUSINESS DEVELOPMENT CASE STUDY

Buy Side Asset Diligence & Portfolio Strategy

BUSINESS DEVELOPMENT CASE STUDY

Strategic Overview

Vault Bioventures was hired to conduct a commercial and clinical assessment of a novel, phase III product, with a goal of maximizing portfolio value through a licensing deal.

Following our integrated product assessment, we identified and proposed a go to market strategy that would provide significant incremental value to the client. Our recommendations were adopted by Senior Management which led to a successful licensing deal.

Outcome

Vault Bioventures buy side diligence and subsequent recommendation resulted in a new product acquisition for our client.

The acquisition represented an incremental increase of $3B in peak sales and optimized portfolio profitability.

Let’s Talk About Your Needs and Goals Today

Contact Us Now

MORE VAULT BIO WORK!

Global Product Positioning & Messaging For New Indication
View Case Study
5-Year Strategic Development and Life Cycle Plan

View Case Study
Briefing Material Development for Successful FDA Approval
View Case Study